[Antitumor effect of calcium phosphate cement incorporating doxorubicin microspheres].
OBJECTIVE
To investigate the antitumor effect of calcium phosphate cement incorporated with doxorubicin microspheres.


METHODS
The absorbance at 490 nm of SaoS-2 cells cultured for 5 days in the media containing the extract of the cement incorporating doxorubicin microspheres was measured using Cell Counting Kit-8. SaoS-2 cells were adjusted to the density of 2x10(7) ml(-1) and injected into the left buttock of nude mouse in the volume of 0.2 ml. The cell suspension (0.1 ml) mixed with an equal volume of the cement extract were injected into the right buttock and on the back of the bilateral ears of nude mice. At 12 days after the cell injection, the tumor tissues were obtained and weighed to calculate the tumor inhibition rate, and the pathological samples were observed with HE staining.


RESULTS
The extract of the bone cement containing doxorubicin microspheres showed inhibitory effects on the tumor growth in a dose-dependent manner. The tumor inhibition rate reached 61.0% in high-dose group. Tumor necrosis was found in high dose group, but virtually absent in low-dose group.


CONCLUSIONS
CPC containing doxorubicin PLGA microspheres can inhibit tumor cell growth both in vitro and in vivo.
Zhang
Hui
H
Department of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China. zhanghuixf@163.com
Xue
Zhong-lin
ZL
Qi
An-min
AM
Li
Sin
S
Ye
Jian-dong
JD
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001843:Bone Cements / Q000494:pharmacology*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000473:pathology; D002130:Calcium Phosphates / Q000494:pharmacology*; D045744:Cell Line, Tumor; D003692:Delayed-Action Preparations; D004317:Doxorubicin / Q000494:pharmacology*; D005260:Female; D008297:Male; D051379:Mice; D008819:Mice, Nude; D008863:Microspheres; D012516:Osteosarcoma / Q000188:drug therapy / Q000473:pathology*
D000903:Antibiotics, Antineoplastic; D001843:Bone Cements; D002130:Calcium Phosphates; D003692:Delayed-Action Preparations; D004317:Doxorubicin; C020243:calcium phosphate